NCT04135690 2023-08-15
HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial
Sun Yat-sen University
Phase 2 Unknown
Clinical Trials
31 trialsNCT04992143 2023-02-16
TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown
NCT04752527 2021-11-15
Individualized Induction Therapy for Non-elderly Acute Myeloid Leukemia Patients With Adverse Risk Features
The First Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT01263951 2021-10-26
Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone
Thomas Jefferson University
Phase 2 Unknown
NCT02638428 2020-03-19
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
Samsung Medical Center
Phase 2 Unknown
NCT00499525 2019-05-03
Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
Northwestern University
Phase 2 Unknown
NCT03812770 2019-04-17
Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC
Sun Yat-sen University
Phase 2 Unknown
NCT03812783 2019-01-23
HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC
Sun Yat-sen University
Phase 2 Unknown
NCT02836847 2018-05-07
Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT02311205 2017-12-18
COTSOM
Asan Medical Center
Phase 2 Unknown
NCT02330783 2017-05-09
Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT02672488 2016-02-03
Metformin Plus Sorafenib for Advanced HCC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT01377025 2014-12-03
STREAM
University Hospital, Essen
Phase 2 Unknown
NCT01272557 2014-04-01
SoraDox
Martin-Luther-Universität Halle-Wittenberg
Phase 2 Unknown
NCT00492505 2014-01-10
Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01222676 2013-08-12
Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01556815 2012-04-25
Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT01170104 2011-06-23
Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)
Chung-Ang University
Phase 2 Unknown
NCT01259193 2011-04-14
Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC
Fudan University
Phase 2 Unknown
NCT00839111 2010-09-15
Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment
Fudan University
Phase 2 Unknown
NCT01182272 2010-08-16
Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01041482 2010-01-06
AGuo
ChineseAMS
Phase 2 Unknown
NCT00874874 2009-12-24
Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00801385 2009-08-25
Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00794859 2009-08-04
SMS
King's College London
Phase 2 Unknown
NCT00722969 2009-03-03
Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer
Free University Medical Center
Phase 2 Unknown
NCT00786110 2009-02-24
PAXO
University of Turin, Italy
Phase 2 Unknown
NCT00844688 2009-02-16
HCC
Combined Military Hospital, Pakistan
Phase 2 Unknown
NCT00772694 2008-10-24
GCT
Fondation Wygrajmy Zdrowie
Phase 2 Unknown
NCT00758381 2008-10-10
MAPS
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Phase 2 Unknown
NCT00752063 2008-09-15
SECOX
The University of Hong Kong
Phase 2 Unknown